Study at a glance
How was vitamin D studied in cells lining the airways?
Two laboratory studies examined human airway-lining cells. One tested whether these cells could activate a vitamin D precursor, a starting form of vitamin D, and change selected defence signals. The other added calcitriol, the active hormone, directly to a cell layer grown in the laboratory and measured how easily substances passed through it.
Could airway cells activate vitamin D and change defence signals?
Primary airway cells converted the precursor and increased selected defence-related signals. Blocking the activating enzyme reduced conversion and weakened those responses. Some signals related to viruses increased the response, but the tested bacterial signals did not act in the same way. Different cell models also behaved differently. Increased production of a defence-related protein did not establish that infections were prevented.
Did active vitamin D reduce passage through the airway-cell layer?
After calcitriol exposure, electrical resistance across the cell layer increased and passage of a small test substance decreased. These direct measurements supported less passage through the layer under the laboratory conditions. Calcitriol partly reduced barrier damage caused by an inflammatory substance. Giving it earlier did not clearly add protection, and the complete mechanism was not established.
Do these cell findings show better lung health from supplements?
The experiments used different cell models and vitamin D exposures. A cell layer grown in the laboratory does not reproduce the whole airway, and the barrier-study cells lacked true cilia, the small moving structures involved in clearing the airways. The studies did not demonstrate a chain from oral supplements to better lung function or fewer infections. They do not establish a respiratory treatment, a COVID-19 benefit or a plan for taking supplements.
Read the full article below ↓Two human airway-cell studies address different parts of epithelial defence: local conversion of vitamin D precursor and measured permeability of a cultured epithelial layer. Together they connect metabolic responsiveness with physical-barrier experiments, without establishing improved respiratory health in people. The companion appraisal is Local Vitamin D Activation, Airway Defence and Epithelial Integrity: Study Summary.
The epithelial question
The airway lining participates in immune surveillance as well as forming a physical boundary. Hansdottir and colleagues asked whether primary tracheobronchial epithelial cells could activate vitamin D locally and whether the resulting response affected selected defence genes. This places the experiment within Vitamin D and Mucosal Defence, while keeping a distinction between immune signalling and a measured physical barrier.
The primary-cell experiments used material from at least three donors. The investigators also examined A549 lung carcinoma cells and human alveolar macrophages. Primary airway cells expressed relatively high CYP27B1, the activating enzyme, and little CYP24A1, which contributes to metabolite breakdown. A549 cells showed the opposite expression pattern and did not produce detectable active vitamin D after 24 hours with 100 nM precursor. Altering the dissociation treatment or culture medium did not explain the expression difference. These findings concern the particular models tested, not every normal or malignant airway cell.
What the cellular model preserves and omits
The macrophage comparison shows why enzyme expression alone is insufficient. Unstimulated alveolar macrophages expressed the activating-enzyme transcript but did not demonstrate precursor conversion under the reported conditions. In contrast, primary airway cells converted precursor without an additional immune stimulus. The distinction between expression, activation and net metabolite production is central to Vitamin D Enzyme Pathways (CYP27B1 / CYP24A1). It prevents a positive RNA measurement from being treated as an automatic demonstration of enzyme activity.
Experiments using cells from several donors help assess whether a response is confined to one preparation. Nevertheless, repeated wells or repeated assays do not represent additional independent people. Donor characteristics, culture conditions and the state of differentiation can influence epithelial responses. A cultured layer also lacks the full combination of recruited immune cells, airway surface fluid, mechanical forces and systemic endocrine regulation found in the intact lung.
The resulting claim is appropriately cellular: these airway epithelial preparations could convert precursor and mount selected vitamin D-responsive responses under the tested conditions. The study was not designed to estimate the frequency or size of that response in the general population. It did not measure whether an oral supplement altered those responses inside a patient’s airway.
Activation and signalling are separate experimental steps
Adding 25-hydroxyvitamin D tests more than receptor responsiveness. For a response mediated by calcitriol, the cells must first have access to precursor and sufficient conversion capacity, with removal of the active metabolite also affecting exposure. Directly supplying calcitriol bypasses that conversion step. Comparing the two exposures therefore helps distinguish local metabolism from the response to an already active signal.
The authors measured calcitriol in culture supernatants after precursor exposure. They then pretreated primary cells with itraconazole, an inhibitor of the activating enzyme. This reduced measured conversion and attenuated precursor-induced expression of CYP24A1, cathelicidin and CD14. The combination connects metabolism with a subsequent transcriptional response more directly than enzyme expression alone. Pharmacological specificity is still limited: the experiment did not selectively delete CYP27B1 or rescue its function. Vitamin D Activation supplies the physiological background for that metabolic step.
For the principal gene-response comparisons, the investigators used 100 nM 25-hydroxyvitamin D or 100 nM calcitriol. They chose the precursor concentration to approximate 40 ng/mL and used the same molar concentration of active hormone for consistency. Equal concentrations are therefore an experimental comparison, not equivalent physiological exposures. Circulating calcitriol normally occurs at much lower concentrations than its precursor, and binding, removal and tissue distribution also differ. The experiment demonstrates cellular capacity without estimating a clinical response to dietary intake.
Antimicrobial gene induction is not a clinical infection outcome
Both precursor and active hormone increased cathelicidin RNA. Intracellular immunoblotting showed predominantly increased hCAP-18 precursor, with a weaker band at the size of mature LL-37; the secreted dot-blot signal did not definitively distinguish the two. Vitamin D and Antimicrobial Peptides explains why precursor production, peptide processing and antimicrobial activity are separate steps. This supplies a specific connection to Vitamin D and Immune Modulation, while leaving pathogen control to be measured directly.
The accompanying CD14 and CYP24A1 responses also show that the cells changed their expression programme. The first is relevant to microbial sensing, while the second participates in vitamin D metabolism. Their induction does not make them interchangeable measures of protection. Vitamin D and Gene Expression is useful here because a coordinated transcriptional response can be demonstrated before, and without, establishing a beneficial clinical outcome.
Clinical protection would require evidence that a defined intervention changed outcomes such as infection incidence, pathogen burden, severity or recovery. Even a change in pathogen burden would need to be distinguished from altered inflammation or tissue damage. The present experiment helps formulate those questions but does not answer them through gene-expression results alone.
The histone-deacetylase inhibitor butyrate enhanced vitamin D-induced cathelicidin and CD14 expression with either precursor or active hormone. This supports an influence of chromatin regulation on the response. It does not identify every required coactivator or establish a safe clinical combination. The result is a regulatory experiment in airway cells and does not establish a gut-to-lung mechanism.
The inflammatory context changes the response
The synthetic double-stranded RNA analogue poly(I:C) increased CYP27B1 expression and precursor conversion after 24 hours. Poly(I:C) alone did not increase cathelicidin transcription, but it amplified the response when precursor was present. Respiratory syncytial virus also increased activation; unlike poly(I:C), the live virus increased cathelicidin without added precursor and amplified it further when precursor was supplied. The responses therefore share a metabolic component without being identical. Neither stimulus increased CYP27B1 in A549 cells.
The tested TLR2 ligands, LAM-MS, Pam3CSK4 and FSL-1, did not increase CYP27B1 expression or augment precursor-induced cathelicidin. These negative comparisons contrast with the viral-stimulus findings and with responses previously reported in other cell types. They prevent the conclusion from being broadened to every innate immune stimulus. The study therefore identifies stimulus-specific regulation within this airway model.
Vitamin D attenuated poly(I:C)-induced IL-8 expression while enhancing the cathelicidin response. This selective regulation connects with Vitamin D and Inflammatory Signalling. IL-8 participates in immune-cell recruitment, so reducing its expression is not automatically synonymous with improved host defence. The balance between pathogen control and inflammatory injury depends on the organism, timing and tissue context. The study did not measure all components of that balance or establish that the observed cytokine change improved respiratory health.
These distinctions help connect the cellular work to Vitamin D and Lung Function without implying that a molecular result predicts spirometry. Airflow measurements, epithelial integrity and immune defence are related aspects of the lung, but they require different assays. The primary-cell activation study did not directly measure resistance across the epithelial layer, paracellular permeability or a restored physical barrier. The separate barrier experiment below supplies direct permeability measurements in a different airway model.
Receptor response and substrate supply
Local production of an active metabolite still needs to be distinguished from the response of its target cell. Vitamin D Receptors explains that recognition step. Measuring conversion and responsive genes together strengthens the pathway interpretation, but it does not establish that receptor abundance is the limiting factor in a patient or that providing additional precursor will improve respiratory outcomes.
Direct measurements of airway barrier integrity
Rybakovsky and colleagues examined a confluent 16HBE 14o: human airway epithelial cell line. Unlike the primary-cell activation experiment, this study directly measured properties of the physical barrier. Electrical resistance across the layer and movement of radiolabelled mannitol across it supplied complementary endpoints. A higher resistance indicates reduced electrical conductance, while lower mannitol passage indicates less movement of that small tracer under the assay conditions. Agreement between them strengthens the inference of altered permeability.
At 50 nM calcitriol for 48 hours, the reported resistance increased by approximately 40% and mannitol flux decreased by approximately 25%, with twelve cell layers per condition in that comparison. The response varied with concentration and time. Resistance and tracer flux did not follow identical time courses, even though improvements persisted during the observation period. This is a useful reminder that a barrier has several transport properties rather than one universal permeability value.
The experimental concentration was an exposure to active hormone in culture, not a dose of oral vitamin D3. The cells were grown as a laboratory layer and did not reproduce an entire airway with mucus flow, recruited immune cells, blood supply and repeated environmental exposures. In particular, 16HBE cells lack true cilia. These differences limit translation to normal respiratory defence even though the measured barrier endpoints were direct.
Tight-junction findings and partial protection from inflammatory injury
Calcitriol was associated with lower claudin-2 abundance in a detergent-soluble cellular fraction. Several other measured junctional proteins did not show the same change, and the result was not evident in whole-cell measurements. The finding therefore depends on which cellular fraction was examined. It supports a change related to junctional organisation but does not prove that claudin-2 alone caused the entire functional effect.
The investigators then challenged the layer with TNF-alpha. Simultaneous calcitriol exposure partly reduced the resulting barrier disturbance, rather than returning every measurement to the untreated state. A preceding 24-hour calcitriol incubation did not clearly add further protection. This negative comparison matters because a preventive timing advantage cannot be inferred merely from the presence of a favourable simultaneous-treatment result.
The study also tested an ERK-pathway inhibitor. That intervention improved resistance, but calcitriol did not reproduce its measured effect on phosphorylated ERK. Combining the interventions produced an additional resistance effect under the inflammatory challenge. The authors proposed a contribution from a pathway other than ERK; they did not identify its complete molecular sequence. Negative measurements of selected death-related markers similarly cannot exclude every possible contribution of cell death or turnover.
Combining the two airway experiments
The activation study supports local conversion and selected defence responses in primary human airway cells. The barrier study shows changes in electrical resistance, tracer passage and junction-associated measurements in a cell line. Together they address immune defence and epithelial integrity more directly than either alone, while preserving their different models and exposures.
They do not form one demonstrated chain from oral supplementation to infection prevention. The barrier experiment supplied calcitriol directly and did not establish that precursor conversion produced the same effect. It also did not expose the model to a respiratory infection and measure patient outcomes. Neither study demonstrates prevention or treatment of COVID-19, a reduction in hospital admission, or a clinically useful supplement regimen. Those propositions require their own intervention evidence.
Conclusion
The studies support two experimentally distinct roles: local vitamin D activation with selected airway defence responses, and altered electrical resistance and tracer permeability after calcitriol exposure in a cultured airway cell line. Primary cells, transformed cell lines and different microbial stimuli did not behave interchangeably. The measured laboratory barrier effects strengthen the physiological account, while clinical infection prevention and respiratory treatment benefit remain untested by these experiments.
Sources and publication details
Respiratory Epithelial Cells Convert Inactive Vitamin D to its Active Form: Potential Effects on Host Defense. Hansdottir S and colleagues. Journal of Immunology. 2008;181:7090 to 7099. DOI: 10.4049/jimmunol.181.10.7090. PMID: 18981129.
Calcitriol modifies tight junctions, improves barrier function, and reduces TNF‐α‐induced barrier leak in the human lung‐derived epithelial cell culture model, 16HBE 14o‐. Rybakovsky E and colleagues. Physiological Reports. 2023;11(7):e15592. DOI: 10.14814/phy2.15592. PMID: 37038908.
Related reading
Activation of Vitamin D Regulates Response of Human Bronchial Epithelial Cells to Aspergillus fumigatus in an Autocrine Fashion
Aspergillus fumigatus (A.
Original paper ↗Read more →Bone health in ambulatory male patients with chronic obstructive airway disease: A case control study from India
Hence, we aim to estimate the prevalence of osteoporosis and metabolic parameters of adverse bone health in patients with COPD.
Original paper ↗Read more →High dose vitamin D3 empowers effects of subcutaneous immunotherapy in a grass pollen-driven mouse model of asthma
We here aim to determine the optimal dose and formulation of VitD3 for the GP SCIT.
Original paper ↗Read more →Metabolic response to extended continuous positive airway pressure in premature infants
Infants ≤32 weeks’ gestational age were randomized to bubble eCPAP with room air or discontinued CPAP (dCPAP).
Original paper ↗Read more →Modulators of Airway Remodeling: The Role of Caffeine and Calcitriol
The aim of the study is to evaluate the effect of calcitriol and caffeine on the expression of genes and proteins associated with airway remodeling.
Original paper ↗Read more →Vitamin D inhibits pro-inflammatory cytokines in the airways of cystic fibrosis patients infected by Pseudomonas aeruginosa: pilot study
We aimed to compare the ability of calcitriol and cholecalciferol to modulate the inflammatory response of the CF airways infected with P.
Original paper ↗Read more →Calcitriol modifies tight junctions, improves barrier function, and reduces TNF‐α‐induced barrier leak in the human lung‐derived epithelial cell culture model, 16HBE 14o‐
Both effects were concentration dependent and active out to 168 h post‐treatment.
Original paper ↗Read more →Local Vitamin D Activation, Airway Defence and Epithelial Integrity: Study Summary
Summary of airway-cell experiments on local vitamin D activation, antimicrobial responses and barrier permeability, with limits on clinical translation.
Read more →Vitamin D and Lung Function
Explore how vitamin D supports lung function through immune regulation, epithelial integrity, inflammatory balance, and whole-system respiratory physiology.
Read more →Vitamin D, Mucosal Surveillance and Local Gut and Airway Defence: Full Evidence Review
Local vitamin D activation, antimicrobial responses and gut-airway differences, with animal contradictions and human respiratory-trial limitations.
Read more →Vitamin D, Mucosal Surveillance and Local Gut and Airway Defence: Study Summary
Plain-English summary of local gut and airway defence studies, conflicting mouse findings and the limits of human infection-trial evidence.
Read more →Local expression profiles of vitamin D-related genes in airways of COPD patients
Therefore, the expression and localization of key enzymes and the receptor of the vitamin D pathway were examined in tissue of 10 unused donor lungs and 10 COPD explant lungs.
Original paper ↗Read more →Effects of calcitriol (1, 25-dihydroxy-vitamin D3) on the inflammatory response induced by H9N2 influenza virus infection in human lung A549 epithelial cells and in mice
Culture supernatants were collected every 24 h post infection and the viral growth kinetics and inflammatory response were evaluated.
Original paper ↗Read more →Maternal vitamin D deficiency impairs Treg and Breg responses in offspring mice and deteriorates allergic airway inflammation
This study aimed at investigating the effects of maternal VitD-deficiency during pregnancy on Treg and Breg responses in offspring mice with house dust mite (HDM)-induced allergic airway inflammation.
Original paper ↗Read more →Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19
In consideration of the role of vitamin D in the immune system, aim of this study was to analyse vitamin D levels in patients with acute respiratory failure due to COVID-19 and to assess any correlations with disease severity and prognosis.
Original paper ↗Read more →Vitamin D deficiency exacerbates bleomycin-induced pulmonary fibrosis partially through aggravating TGF-β/Smad2/3-mediated epithelial-mesenchymal transition
The objective of this study was to further investigate whether vitamin D deficiency exacerbates BLM-induced pulmonary fibrosis.
Original paper ↗Read more →Evaluating the Role of BglI rs739837 and TaqI rs731236 Polymorphisms in Vitamin D Receptor with SARS-CoV-2 Variants Mortality Rate
This study aimed to evaluate the relationship between the BglI rs739837 and TaqI rs731236 polymorphisms and the mortality rate of COVID-19 based on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants.
Original paper ↗Read more →Evaluation the level of vitamin D and its relationship with clinical symptoms in patients with COVID-19 referred to the medical center in Bam city
A checklist consisting of demographic variables was used to gather data, and laboratory assessments of serum 25(OH) D were evaluated and documented.
Original paper ↗Read more →Human Metapneumovirus Infection Inhibits Cathelicidin Antimicrobial Peptide Expression in Human Macrophages
Human cathelicidin antimicriobial peptide (CAMP) is a critical component of host innate immunity with both antimicrobial and immunomodulatory functions.
Original paper ↗Read more →Retrospective Clinical Investigation into the Association Between Abnormal Blood Clotting, Oral Anticoagulant Therapy, and Medium-Term Mortality in a Cohort of COVID-19 Patients
People affected by COVID-19 are exposed to abnormal clotting and endothelial dysfunction, which may trigger thromboembolic events.
Original paper ↗Read more →The impact of calcitriol and estradiol on the SARS-CoV-2 biological activity: a molecular modeling approach
The novel coronavirus disease (COVID-19) is currently a big concern around the world.
Original paper ↗Read more →Original sources
Respiratory Epithelial Cells Convert Inactive Vitamin D to its Active Form: Potential Effects on Host Defense
Published in Hansdottir S and colleagues. Journal of Immunology (2008).
Publication details
Respiratory Epithelial Cells Convert Inactive Vitamin D to its Active Form: Potential Effects on Host Defense. Hansdottir S and colleagues. Journal of Immunology. 2008;181:7090 to 7099. DOI: 10.4049/jimmunol.181.10.7090. PMID: 18981129.
Calcitriol modifies tight junctions, improves barrier function, and reduces TNF‐α‐induced barrier leak in the human lung‐derived epithelial cell culture model, 16HBE 14o‐
Both effects were concentration dependent and active out to 168 h post‐treatment.
Publication details
Calcitriol modifies tight junctions, improves barrier function, and reduces TNF‐α‐induced barrier leak in the human lung‐derived epithelial cell culture model, 16HBE 14o‐. Rybakovsky E and colleagues. Physiological Reports. 2023;11(7):e15592. DOI: 10.14814/phy2.15592. PMID: 37038908.